How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

On February 5, 2026, OpenAI introduced GPT-5.3-Codex and wrote in its release notes that early versions of the model were “instrumental in creating itself,” helping to debug training runs, manage ...

Performs recursive feature elimination to find optimal feature subset. Tracks performance at each step and identifies best configuration.

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Membership today. It is, perhaps, the ultimate promise of artificial intelligence: AI systems ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recent insider activity at Recursion Pharmaceuticals included 2 transactions totaling $97,222.74. One was a Tax Payment of $18,400.36 and the other was a Sale of $78,822.38. Average transaction ...

Liquid AI released d1-ultra, a text and image decision model that returns calibrated probabilities in 1 forward pass. It ...

Introduction Teams shipping AI agents at scale keep running into the same pattern. Even agents built on top-tier models like ...